BioPharma Dive86d agobullish
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from CelgeneNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
FastCompany87d agobearish
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get moneyInsider Monkey87d agoneutral
Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line Performance24/7 Wall St.87d agobearish
Ellison Is Now Willing to Sell CNN to Save His $111 Billion Deal. It Wouldn’t End the Lawsuit.Pharmaceutical Technology87d agobearish
Eli Lilly cracks down on illicit weight loss drug trade with US lawsuitsSimply Wall St.87d agobearish
Is Charles Schwab (SCHW) At Greater Risk After A 13,000 Customer Lawsuit?Investing.com88d agoneutral
Paramount puts CNN sale on table to settle 12-state antitrust suitBenzinga Prediction Markets88d agobearish
Coinbase, Polymarket, Kalshi Face NYC Prediction Market InvestigationBioPharma Dive88d agobearish
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutideThe Wall Street Journal88d agobearish
New York City Launches Sweeping Investigation Into Polymarket and KalshiSimply Wall St.89d agobearish
Meta Platforms (META) Opens AI Models As $1 Billion Fund And Lawsuits Add PressureClinical Trials Arena90d agoneutral
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA marketInsider Monkey90d agoneutral
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?MediaPost93d agoneutral
Tougher Google Antitrust Penalties Would Threaten Firefox, Mozilla WarnsSimply Wall St.93d agobearish
Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of LawsuitsSimply Wall St.93d agobearish
What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?